Acute causes of sudden deaths in patients with severe hypoglycemia

Česká verzia

Authors: Tomáš Bolek; Matej Samoš; Michal Mokáň; Peter Galajda; Marián Mokáň
Authors place of work: I. interná klinika Jesseniovej LF UK a UN Martin, Slovenská republika
Published in the journal: Vnitř Lék 2016; 62(6): 462-466
Category: Reviews

Summary

Hypoglycemia is a serious event, which is associated with the neurological and cardiovascular events. Hypoglycemia can be also associated with sudden death, however, the prevalence of these sudden deaths is not exactly known. Hypoglycemia is associated with the risk of sudden death in patients with type 1. and 2. type diabetes mellitus and also in critically ill patients. Sudden death can occure due to cardiovascular, neurological or metabolic disorders associated with hypoglycemia. The article provides a review of current knowledge about the prevalence of severe hypoglycemia, the association between hypoglycemia and sudden deaths and about the causes of sudden death in patients with severe hypoglycemia.

Key words:
hypoglycemia – prevalence of these sudden deaths – severe hypoglycemia

Zdroje

1. Mokáň M. Hypoglycaemia. Vnitř Lék 2008; 54(4): 387–394.

2. Alonso-Morán E, Orueta JF, Nuño-Solinís R. Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on health care costs. BMC Health Serv Res 2015; 15: 207. Dostupné z DOI: <http://dx.doi.org/10.1186/s12913–015–0876–2>.

3. Paty BW. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes. Can J Diabetes 2015; 39(Suppl 5): S155-S159.

4. Samoš M, Kalinová S, Galajda P et al. Hypoglykémia u hospitalizovaných pacientov bez diabetes mellitus. Diabetes a obezita 2012; 12: 53–58.

5. Goff DC Jr, Gerstein HC, Ginsberg HN et al. [ACCORD Study Group]. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007; 99(12A): 4i-20i.

6. Chalmers J, Perkovic V, Joshi R et al. ADVANCE: breaking new ground in type 2 diabetes. J Hypertens Suppl 2006; 24(5): S22-S28.

7. Kirkman MS, McCarren M, Shah J et al. VADT Study Group. The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes. J Diabetes Complications 2006; 20(2): 75–80.

8. Bedenis R, Price AH, Robertson CM et al. Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study. Diabetes Care 2014; 37(12): 3301–3308.

9. Graveling AJ, Frier BM. Review: Does hypoglycaemia cause cardiovascular events? Br J Diabetes Vasc Dis 2010; 10(10): 5–13.

10. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008; 24(5): 353–363.

11. Zoungas S, Patel A, Chalmers J et al. [ADVANCE Collaborative Group]. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363(15): 1410–1418.

12. Mellbin LG, Rydén L, Riddle MC et al. [ORIGIN Trial Investigators]. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J 2013; 34(40): 3137–3144.

13. Goto A, Arah OA, Goto M et al. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533. Dostupné z DOI: http://dx.doi.org/10.1136/bmj.f4533.

14. Sanon VP, Sanon S, Kanakia R et al. Hypoglycemia from a cardiologist’s perspective. Clin Cardiol 2014; 37(8): 499–504.

15. Frier BM, Schernthaner G, Heller SR. Hypoglycemia and Cardiovascular Risks. Diabetes Care 2011; 34(Suppl 2): S132-S137.

16. Pistrosch F, Ganz X, Bornstein SR et al. Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditions. Acta Diabetol 2015; 52(5): 889–895.

17. Little CJ. Hypoglycaemic bradycardia and circulatory collapse in a dog and a cat. J Small Anim Pract 2005; 46(9): 445–448.

18. Gill GV, Woodward A, Casson IF et al. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the “dead in bed” syndrome revisited. Diabetologia 2009; 52(1): 42–45.

19. Tu E, Twigg SM, Semsarian C. Sudden death in type 1 diabetes: the mystery of the ‘dead in bed’ syndrome. Int J Cardiol 2010; 138(1): 91–93.

20. Dungan KM, Binkley P, Nagaraja HN et al. The impact of glycemic control and glycemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes Metab Res Rev 2011; 27(1): 85–93.

21. Arbeláez AM, Su Y, Thomas JB et al. Comparison of regional cerebral blood flow responses to hypoglycemia using pulsed arterial spin labeling and positron emission tomography. PLoSOne 2013; 8(3): e60085. Dostupné z DOI: http://dx.doi.org/10.1371/journal.pone.0060085.

22. Sontineni SP, Lee JM, Porter J. Hypoglycemia-induced pontine infarction in a diabetic male with basilar artery stenosis: insight in to the mechanisms of hypoglycemic stroke. Cerebrovasc Dis 2008; 25(3): 281–282.

23. Yu TM, Lin CL, Chang SN et al. Increased risk of stroke in patients with chronic kidney disease after recurrent hypoglycemia. Neurology 2014; 83(8): 686–694.

24. Sturner WQ, Sullivan A. Hypoglycemia as the responsible factor in a truck driver accident fatality. J Forensic Sci 1983; 28(4): 1016–1020.

25. Cox DJ, Kovatchev BP, Anderson SM et al. Type 1 diabetic drivers with and without a history of recurrent hypoglycemia-related driving mishaps: physiological and performance differences during euglycemia and the induction of hypoglycemia. Diabetes Care 2010; 33(11): 2430–2435.

26. Kennedy RL, Henry J, Chapman AJ et al. Accidents in patients with insulin-treated diabetes: increased risk of low-impact falls but not motor vehicle crashes – a prospective register-based study. J Trauma 2002; 52(4): 660–666.

27. Kachroo S, Kawabata H, Colilla S et al. Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. commercial database. J Manag Care Spec Pharm 2015; 21(3): 243–253.

28. Samoš M, Galajda P, Mokáň M et al. Hypoglykémia u pacientov hospitalizovaných na internom oddelení: prevalencia a najčastejšie príčiny jej vzniku. Forum Diab 2014; 3(1): 34–39.

29. Price WA, Zimmer B, Conway R et al. Insulin-induced factitious hypoglycemic coma. Gen Hosp Psychiatry 1986; 8(4): 291–293.

30. Ben-Ami H, Nagachandran P, Mendelson A et al. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999; 159(3): 281–284.

31. Furukawa S, Kumagi T, Miyake T et al. Suicide attempt by an overdose of sitagliptin, an oral hypoglycemic agent: a case report and a review of the literature. Endocr J 2012; 59(4): 329–333.

32. Carlsen SM. Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition. Tidsskr Nor Laegeforen 1997; 117(21): 3079–3082.

33. Singh M, Jacob JJ, Kapoor R et al. Fatal hypoglycemia with levofloxacin use in an elderly patient in the post-operative period. Langenbecks Arch Surg 2008; 393(2): 235–238.

34. Wang S, Rizvi AA Levofloxacin-induced hypoglycemia in a non diabetic patient. Am J Med Sci 2006; 331(6): 334–335.

35. Finfer S, Liu B, Chittock DR et al. [NICE-SUGAR Study Investigators]. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367(12): 1108–1118